Department of Specific Pediatric Chronic Disease Information, National Center for Child Health and Development, Tokyo, Japan.
Graduate School of Advanced Integrated Studies in Human Survivability, Kyoto University, Kyoto, Japan.
Am J Med Genet A. 2022 Jan;188(1):224-236. doi: 10.1002/ajmg.a.62526. Epub 2021 Oct 7.
Despite the higher mortality rates in patients with Down syndrome compared with the general Japanese population, the life span has dramatically increased in Japan and other countries. We aimed to clarify recent causes of death in patients with Down syndrome in Japan. We calculated proportionate mortality and standardized mortality odds ratios (SMORs) among all deaths registered with Down syndrome as the cause of death (ICD-10 code, Q90) in the Japanese National Death Registry Database in 2014-2016. In the study period, 762 in patients with Down syndrome died. The main causes of death were pneumonia/respiratory infections (20.5%), congenital malformations of the circulatory system (11.2%), other diseases of the circulatory system (9.2%), and aspiration pneumonia (8.4%). The SMORs (95% confidence intervals) were higher for natural death, defined as death of an elderly person with no other cause of death to be mentioned (55.73 [36.92-84.12]), early-onset Alzheimer's disease, defined as Alzheimer's disease with onset <65 years of age (29.36 [16.44-52.44]), aspiration pneumonia (18.33 [14.03-23.96]), pneumonia/respiratory infections (8.11 [6.76-9.73]), congenital malformations of the circulatory system (8.07 [5.98-10.88]), and leukemia/lymphoma (2.16 [1.55-2.99]) but lower for malignant solid tumors (0.04 [0.02-0.06]) in patients with Down syndrome. Patients with Down syndrome had the greatest relative risk of dying from natural death, early-onset Alzheimer's disease, and respiratory illnesses, highlighting the need for appropriate medical, health, and welfare services.
尽管唐氏综合征患者的死亡率高于普通日本人群,但在日本和其他国家,患者的寿命已经显著延长。我们旨在阐明日本唐氏综合征患者的近期死因。我们计算了 2014-2016 年日本国家死亡登记数据库中以唐氏综合征为死因(ICD-10 编码 Q90)登记的所有死亡病例的比例死亡率和标准化死亡率比值(SMOR)。在研究期间,有 762 名唐氏综合征患者死亡。主要死因是肺炎/呼吸道感染(20.5%)、先天性循环系统畸形(11.2%)、其他循环系统疾病(9.2%)和吸入性肺炎(8.4%)。SMOR(95%置信区间)更高的是自然死亡,即无其他死因可归因的老年人死亡(55.73[36.92-84.12])、早发性阿尔茨海默病,即发病年龄<65 岁的阿尔茨海默病(29.36[16.44-52.44])、吸入性肺炎(18.33[14.03-23.96])、肺炎/呼吸道感染(8.11[6.76-9.73])、先天性循环系统畸形(8.07[5.98-10.88])和白血病/淋巴瘤(2.16[1.55-2.99]),但恶性实体肿瘤(0.04[0.02-0.06])的 SMOR 较低。唐氏综合征患者死于自然死亡、早发性阿尔茨海默病和呼吸道疾病的相对风险最高,这突出表明需要提供适当的医疗、保健和福利服务。